Background: Low income pregnant women have a higher prevalence of Intimate Partner Violence (IPV). IPV around the time of pregnancy is a risk factor for adverse pregnancy and birth outcomes. The Supplemental Nutrition Program for Women, Infants, and Children (WIC) available to low income pregnant women may provide an opportunity to identify victims of IPV and refer them to services. The association between IPV and utilization of WIC services is not well studied. This study aims to determine the associations between IPV before and during pregnancy and WIC participation among women who recently gave birth in the United States. Methods: The 2004 – 2011 National Pregnancy Risk Assessment Monitoring System (PRAMS) survey (n= 319,689) was analyzed. Self-reported WIC participation and pre-pregnancy IPV and IPV during pregnancy were examined. Multiple logistic regression analysis was conducted and adjusted odds ratios and corresponding 95% confidence intervals were calculated. Subpopulation analysis was conducted stratified by race/ethnicity. Results: Nearly half of the study sample received WIC (48.1%) and approximately 4% of women reported physical abuse 12 months before their most recent pregnancy and 3% reported abuse during pregnancy. Women who reported IPV, both before and during pregnancy, had significantly higher odds of WIC utilization compared to women who did not report IPV, even after adjusting for confounders such as maternal age and education, paternal education, marital status, insurance before pregnancy, number of barriers to prenatal care visits, and pregnancy intention. No significant racial differences were observed in the association between IPV, both before and during pregnancy, and utilization of WIC, after adjusting for confounders. Conclusion: There is a significant association between IPV before and during pregnancy and utilization of WIC. Public health professionals and WIC service providers/counselors should be aware of this association and use this opportunity to address and intervene with the adverse effects of IPV around the time of pregnancy.